What does GlycoMimetics Inc’s (NASDAQ:GLYC) abstract data for the American Society for Clinical Oncology (ASCO) bring to the table for acute myeloid leukemia …
It’s a very rewarding trading day for investors in GlycoMimetics Inc (NASDAQ:GLYC) with shares up over 70%, making the stock Wall Street’s bull …
Written by Dan Cohen and Scott Matusow At Stockmatusow, our primary focus is finding clinical stage biotech companies that have the potential to …